- 9:00 - 10:00 am Newer Generation of Antipsychotics - Part 2
- Abdolreza Saadabadi, MD and Mandeep Bagga, MD
- 10:00 - 10:05 am Break | Visit Poster Presentations
- 10:05 – 11:05am Psychedelics in Psychiatry
- Charles Grob, MD
- 11:05 – 11:10 am Break | Visit Poster Presentations
- 11:10 – 12:10 pm Resident Vignette Presentations - Part 1
- 12:10 – 1:10 pm Break | Visit Poster Presentations
- 1:10 – 2:10 pm Resident Vignette Presentations - Part 2
- 2:10 – 2:15 pm Break | Visit Poster Presentations
- 2:15 - 2:45 pm Poster & Vignette Award Presentations
Abdolreza Saadabadi, MD
Dr. Saadabadi completed his psychiatry residency and child and adolescent psychiatry fellowship at UCLA-Kern program and became boarded certified in both adult and child psychiatry in 2013 and 2014. Since his graduation, he has been the teaching faculty at UCLA Kern and Kaweah Delta Psychiatry Residency program. Currently he is the chair of Psychiatry and Addiction Medicine Department and Medical Director at Kaweah Delta Heathcare District in Visalia and Supervising faculty at UCLA-Kern Child and Adolescent Psychiatry Fellowship Program.
Mandeep Bagga, MD
Mandeep Bagga is a board-certified adult psychiatrist who graduated from East Carolina University in North Carolina. He is the program director of the Adult Psychiatry Residency Training Program at Kaweah Health is Visalia, California. He also serves as the Vice Chair of the Department of Psychiatry and Neurosciences. He has a particular interest in technology, the business of medicine, empowering physicians, and education. He has research interests in utilizing new and emerging technologies to improve healthcare outcomes, reduce morbidity, improve patient wellbeing, while simultaneously reducing physician workload and burnout.
Charles Grob, MD
Dr. Grob is Professor of Psychiatry and Pediatrics at the UCLA School of Medicine and the Director of the Division of Child and Adolescent Psychiatry at the Harbor-UCLA Medical Center. He previously held faculty positions at the Johns Hopkins School of Medicine and the University of California at Irvine. He has conducted approved clinical research with psychedelics since the early 1990s. From 2004-2008 he was the Principal Investigator of the first study in several decades to examine the use of a psilocybin treatment model for patients with advanced-cancer anxiety. He has also conducted research into the range of effects of MDMA, in both normal volunteers and in a selected subject population of adult autistics with severe social anxiety. And, he has conducted a series of ayahuasca research studies in Brazil. Over the last thirty years Dr. Grob has published numerous articles and chapters on psychedelics in the medical and psychiatric literatures and he is the editor of Hallucinogens: A Reader (Putnam/Tarcher, 2002), co-editor (with Roger Walsh) of Higher Wisdom: Eminent Elders Explore the Continuing Impact of Psychedelics (SUNY Press, 2005) and co-editor (with James Grigsby) of the recently published Handbook of Medical Hallucinogens (Guilford Press, 2021). He is a founding board member of the Heffter Research Institute.